← Back to Entity Graph

Australian Foundation For Diabetes Research

Concentration Risk
FoundationRegistryHPCABN 97097263824NSW
Relationships
20
Data Sources
2
Revenue
$123K
Tax Payable
Preview
Data as of: 17 June 2026
Found in 2 systemsACNC CharitiesFoundations

Giving Philosophy

The foundation believes science holds the key to ending diabetes. It prioritizes funding research that develops practical therapies to improve quality of life for insulin-dependent Australians, combined with community education about therapeutic advances.

Wealth Source:Corporate foundation established in 2001; specific corporate source not publicly detailed.

Tips for Applicants

Target research proposals focused on insulin-dependency reduction and diabetes therapy development. Align applications with the foundation's emphasis on practical, life-improving treatments for young people with diabetes and include community education components where possible.

Notable Grants

  • Research funds provided to the University of Sydney to promote the Foundation's aims.
  • Funding for the development of human embryonic stem cell lines and isolation of insulin-producing cells.
  • Support for placing human insulin-producing cells inside microcapsules and isolation/transplantation of the human fetal pancreas.
  • Collaboration and funding for 'The Bioengineered Diabetes Therapy Project' with Queensland University of Technology.
  • Scholarships for PhD students (e.g., Luke Carroll, Vijay Vaithilingam, Mathi Appavoo).
  • Salary support for Post-Doctoral Fellows (e.g., Dr. Marie Best).
  • Travel funds for researcher training and visiting research fellows.
  • Participation in a bi-national research grant with Israeli biotechnology company Kadimastem (2018) for cell-based therapy and encapsulation solutions for diabetes.

Financial History (7 years)

YearRevenueExpensesAssetsSurplus
2023$123K$88K$792K$34K
2022$201K$156K$816K$45K
2021$272K$308K$835K$-36,101
2020$537K$98K$879K$439K
2019$285K$198K$434K$87K
2018$86K$88K$343K$-2,495
2017$110K$219K$310K$-109,201
0
Grants Given (AU)
$69K
0
Volunteers
6
Donations Received
$7K

Community Evidence

External Evidence

Identity

GS ID
AU-ABN-97097263824
ABN
97097263824
Sector
health
Financial Year
2023

Focus Areas

Themes
health
Geography
AU-National
Target Recipients
disability
Purposes
HealthGeneral Public
Beneficiaries
Chronic IllnessDisability

Financials

Revenue
$123K
Assets
$792K

Method

Match Confidence
registry
Cross-references
2 datasets
Match Key
ABN
Relationships
20

Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.

Data Sources

ACNCFoundations

JusticeHub

External Link

This entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.

External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.

View on JusticeHub

Location Intelligence

Postcode
2035
Locality
Maroubra - South
Remoteness
Major Cities of Australia
SEIFA Disadvantage
Decile 8/10
LGA
Bayside (NSW)
Entities in Area
223
View on Power Map

Disability Market Context

NDIS Layer
State Providers
4,591
Thin Districts
2
Very Thin
1
Local Alternatives
0
8 community-controlled orgs in postcode

This organisation shows disability-related delivery signals. The strategic question is whether it sits inside a resilient market, a thin market, or a captured market where large providers take most of the money and local alternatives are scarce.

Thinnest Districts In NSW
Far West49 providers
Far West51 providers
Southern NSW242 providers
Captured Markets
Far West95%
Mid North Coast89%
Western NSW75%
Murrumbidgee71%